CClinicalTrials.gg
CompletedNCT03639272TTF2017Updated Aug 21, 2018

Treatment of Talus Fractures: a Retrospective Study

An observational study in Talus Fracture, sponsored by University of Padova. Completed. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-08-21.

Sponsored by University of Padova · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
40
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The main purpose of this retrospective case series study was to evaluate long-term radiographic and clinical outcomes of a consecutive series of patients with diagnosis of isolated, displaced, closed talar neck or body fractures treated by open reduction and internal fixation. Secondly, it was aimed to verify the influence of the location of talar fractures on the outcomes, the prognostic value of the Hawkins sign, whether operative delays promote avascular necrosis (AVN) and if the fractures require emergent surgical management.

Read the detailed description

From January 2007 to December 2012, 31 patients underwent ORIF by screws at our institution. On the basis of Inokuchi criteria, the injuries were divided between neck and body fractures, which were classified according to Hawkins and Sneppen, respectively. The patients included were divided into two groups in relation to fracture location and complexity. Radiographic assessment focused on reduction quality, bone healing, Hawkins sign and osteoarthritis development. For clinical evaluation, clinical-functional scores (AOFAS Ankle-Hindfoot Score; MFS; FFI-17; SF-36) and VAS were determined, and statistical analysis was performed.

02

Conditions studied

  • Talus Fracture

Browse trials for

Keywords

  • talar fractures
  • talar neck fractures;
  • talar body fractures;
  • talus;
  • ORIF;
  • screw fixation.
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 40 is below the median of 100 across 675 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

University of Padova is the lead sponsor of 210 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

There were 19 men (1 bilateral case for a total of 20 fractures, 71.4%) and 8 women (29.6%). Overall, mean age at the time of injury was 38.3 years old (range 18-81)

Inclusion criteria

  • diagnosis of a closed, isolated, displaced talar neck or body fracture with 2 or more millimetres displacement, subsequently treated by ORIF
  • age between 18 and 85 years
  • informed consent to participate.

Exclusion criteria

Exclusion Criteria:

  • undisplaced fractures or involvement of both the neck and the body,
  • open fractures, talar head and peripheral fractures including posterior process, osteochondral fractures, primary arthrodesis or amputation,
  • history of severe neurological deficit,
  • previous foot surgery or trauma,
  • diagnosis of rheumathological diseases or psoriatic arthritis, foot neuropathy, severe vascular insufficiency and alcohol or drug abuse.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
40 participants (actual)
Patient registry
No

Interventions

  • Procedureopen reduction and internal fixation (ORIF).

    Depending on the fracture location, a single anteromedial or anterolateral approach was carried out. The fracture site was cleaned to make it visible, allowing anatomical reduction. Subsequently, fixation of provisional fragments was achieved using temporary Kirschner wires under radiographic guidance. Having obtained satisfactory reduction as seen with the radiographic intensifier, definitive fixation of the main bone fragments was carried out using two or more 3.5 mm titanium cannulated screws or 4.0 mm lag screws, placed anteriorly to posteriorly. Fractures complicated by severe comminution necessitated 3.5 mm cortical screws in order to avoid shortening, translation or angulation of the fragments.

    Also known as: ORIF

06

What researchers measure

Primary outcomes

  1. Evaluation of the quality reduction after surgery

    Radiographic examination of anteroposterior, lateral and oblique view radiographs enabled to evaluate the quality of the reduction. Any offset of more than 2 mm or neck angulation of more than 5° between the fragment was labelled as a poor reduction.

    Time frame: at day 1 after surgery

  2. Evaluation of bone healing

    Criteria to define bone healing and union: The bridging bone/callus formation was evaluated on radiographs The absence of radiolucent lines was verified at different follow-ups.

    Time frame: at different follow-ups (1 month, 3 months, 6 months, 12 months, 24 months)

  3. Evaluation of osteonecrosis

    The Hawkins sign appearance (only on the A/P X-ray), which resembles a subchondral atrophy in the talus dome, was evaluated indicating that the talus is well vascularized. On the contrary, its absence at this time suggests the presence of osteonecrosis

    Time frame: at 6-8 weeks after injury

  4. Evaluation of the development of post-injury peritalar osteoarthritis

    Post-injury peritalar osteoarthritis was evaluated on X-ray and differentiated between necrosis without collapse (sclerosis with and without geodes) and necrosis with collapse of the talar dome at the last follow-up

    Time frame: at last follow-up (seven years)

Secondary outcomes

  1. American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot score

    The AOFAS score enabled to quantify pain and functional disability. It includes 9 questions related to pain (1 question; 40 points), function (7 questions; 50 points) and alignment (10 questions; 10 points); a score of 90-100 is considered an excellent result; 75-89 as good; 50-74 as fair and less than 49 points is considered a failure or a poor outcome.

    Time frame: at last follow-up (seven years)

  2. the Maryland Foot Score (MFS)

    The MFS is a score conceptually analogous to AOFAS score, but points are differently distributed (45 for pain, 55 for functional limitation); they indicate excellent results if the score is between 90 to 100, good for a score of 75 to 89, fair for a score of 50 to 74 and poor if the score is \< 50.

    Time frame: at last follow-up (seven years)

  3. the 17-Foot Functional Index (FFI-17)

    The FFI-17 measures the persistence of pain, disability and restriction of activity, with 17 number-rating scales from 0 to 10. The maximum score is 100, which indicates complete disability.

    Time frame: at last follow-up (seven years)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03639272
Lead sponsor
University of Padova
Responsible party
Carlo Biz (Orthopedic surgeon, Assistant Professor, University of Padova) — Principal investigator
First posted
Aug 21, 2018
Start date
Jan 1, 2007
Primary completion
Dec 31, 2012
Completion
Feb 28, 2018
Last update
Aug 21, 2018

Study contacts

Carlo Biz, MD
principal investigator · Padua University Orthopaedic Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion